IL-15 has the potential to boost CAR-T- cell antitumor activity and self-renewal capability by enhancing cytotoxicity and balancing the tumor microenvironment.25 This suggests a strategy to enhance the effectiveness and durability of CAR-T cell immunotherapy. This evidence concerns the gene IL15 and neoplasm.